Skip to main content
Clinical Trials/NCT03930199
NCT03930199
Active, not recruiting
Not Applicable

Personalized Mobility Interventions Using Smart Sensor Resources for Lower-Limb Prosthesis Users

Shirley Ryan AbilityLab3 sites in 1 country66 target enrollmentMay 1, 2020
ConditionsAmputation

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Amputation
Sponsor
Shirley Ryan AbilityLab
Enrollment
66
Locations
3
Primary Endpoint
Pre-intervention: 6 Minute Walk Test (6MWT)
Status
Active, not recruiting
Last Updated
3 months ago

Overview

Brief Summary

The goal of this research is to analyze data from smartphone-based and wearable sensors, using advanced machine-learning and data-mining techniques, and to combine this information with performance-based measures, participant-reported measures, and structured interviews to create a clinical toolbox to (i) identify individuals who exhibit reduced prosthesis use (compared to expected usage levels based on K-level designation and/or participant goals of community mobility and social interaction), (ii) identify prosthetic/physical and psychological factors that limit prosthesis use, and (iii) determine the effect of targeted interventions to increase prosthesis use and facilitate achievement of participant goals. Objective sensor-based measurement of home and community activities will allow for the correlation of real-world function to in-clinic assessments and to monitor changes resulting from rehabilitation interventions in real time. Machine-learning and data mining techniques will be used to identify a subset of measures from this toolbox that sensitively and accurately reflect real-world function, enabling clinicians to predict and assess activity and provide effective interventions to optimize prosthesis use. The goal of this project, to improve overall performance with respect to activities of daily living and other real-world activities, thus addresses the Fiscal Year 2017 (FY17) Orthotics and Prosthetics Outcomes Research Program (OPORP) Focus Area of Orthotic or Prosthetic Device Function.

Detailed Description

The overall goal of this research is to create a clinical toolkit to predict prosthesis use and function in the community. With this toolkit, clinicians will be able best determine an individual's K-Level designation, resulting in increased prosthesis use. Aim 1: Determine whether a participant's prosthesis use matches the assigned K-level and/or self-reported goals and, if not, determine the reason(s) using an expert panel to evaluate data from performance-related measures, participant-reported measures, and smartphone and prosthesis sensors (clinical toolbox). Aim 2: Quantify the effects of targeted physical intervention (prosthesis repair/refit, physical rehabilitation) or psychological intervention (motivational interviewing) or both on activity levels and patient goals. Aim 3: Identify measure(s) that sensitively predict prosthesis use to create a clinically deployable toolkit to evaluate and optimize prosthesis use in the community.

Registry
clinicaltrials.gov
Start Date
May 1, 2020
End Date
December 31, 2026
Last Updated
3 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Arun Jayaraman, PT, PhD

Principal Investigator

Shirley Ryan AbilityLab

Eligibility Criteria

Inclusion Criteria

  • Unilateral or bilateral lower limb amputation at transtibial or transfemoral level
  • Ability to wear and use a prosthesis
  • Designated K-level 2 - 4, or equivalent
  • Prescription of definitive prosthesis
  • Veterans Affairs participants must receive care through the Veterans Affairs or related remote-site clinic
  • Age: 18-89 years-to reflect the age range of eligible participants at Department of Defense and Veterans Affairs study sites, including young, combat-injured Service Members and healthy older Veterans, aged 70-80.

Exclusion Criteria

  • Co-morbidities that limit prosthesis use, independently of prosthetic function, training, or motivation, such as stroke, obesity, severe traumatic brain injury, and neuralgia, which require interventions outside the scope of this study. Suitability to participate in the study will be determined by the individual's physician.
  • Unable or unwilling to learn to use the smartphone app or to allow transmission of study data
  • Unable or unwilling to provide informed consent
  • Residing in an area with poor cell phone coverage

Outcomes

Primary Outcomes

Pre-intervention: 6 Minute Walk Test (6MWT)

Time Frame: Week 12-13

The 6 minute walk test is performed as an objective evaluation of functional exercise capacity. The test measures the distance that the patient can walk on a flat, hard surface, indoors, in a period of 6 minutes. The walk test is patient self-paced and assesses the level of functional capacity. Patients are allowed to stop and rest during the test, however, the timer does not stop. If the patient is unable to complete the time, the time stopped is noted and reason for stopping prematurely is recorded.

Post-intervention:10 Meter Walk Test (10MWT)

Time Frame: Week 24-25

Assesses subject walking speed in meters per second for 10 meters. Subjects will repeat each measure 3 times at their normal self-selected walking speed and 3 times at a fast speed while still able to maintain safety.

Post-intervention: 6 Minute Walk Test (6MWT)

Time Frame: Week 24-25

The 6 minute walk test is performed as an objective evaluation of functional exercise capacity. The test measures the distance that the patient can walk on a flat, hard surface, indoors, in a period of 6 minutes. The walk test is patient self-paced and assesses the level of functional capacity. Patients are allowed to stop and rest during the test, however, the timer does not stop. If the patient is unable to complete the time, the time stopped is noted and reason for stopping prematurely is recorded. This test will be administered while wearing a mask to measure oxygen consumption.

Post-intervention: Berg Balance Scale Test

Time Frame: Week 24-25

This test is a standardized 14-item objective measure of postural stability and static balance; it is an established fall predictor in adults. Balance is measured during various tasks on a 5 point scale, ranging from 0-4. "0" indicates the lowest level of function and "4" the highest level of function, with a total possible score of 56. A score of 20 or less indicates a high fall risk.

Delayed post-intervention:10 Meter Walk Test (10MWT)

Time Frame: Week 40-41

Assesses subject walking speed in meters per second for 10 meters. Subjects will repeat each measure 3 times at their normal self-selected walking speed and 3 times at a fast speed while still able to maintain safety.

Delayed post-intervention: 6 Minute Walk Test (6MWT)

Time Frame: Week 40-41

The 6 minute walk test is performed as an objective evaluation of functional exercise capacity. The test measures the distance that the patient can walk on a flat, hard surface, indoors, in a period of 6 minutes. The walk test is patient self-paced and assesses the level of functional capacity. Patients are allowed to stop and rest during the test, however, the timer does not stop. If the patient is unable to complete the time, the time stopped is noted and reason for stopping prematurely is recorded. This test will be administered while wearing a mask to measure oxygen consumption.

Delayed post-intervention: Berg Balance Scale Test

Time Frame: Week 40-41

This test is a standardized 14-item objective measure of postural stability and static balance; it is an established fall predictor in adults. Balance is measured during various tasks on a 5 point scale, ranging from 0-4. "0" indicates the lowest level of function and "4" the highest level of function, with a total possible score of 56. A score of 20 or less indicates a high fall risk.

Pre-intervention:10 Meter Walk Test (10MWT)

Time Frame: Week 12-13

Assesses subject walking speed in meters per second for 10 meters. Subjects will repeat each measure 3 times at their normal self-selected walking speed and 3 times at a fast speed while still able to maintain safety.

Pre-intervention: Berg Balance Scale Test

Time Frame: Week 12-13

This test is a standardized 14-item objective measure of postural stability and static balance; it is an established fall predictor in adults. Balance is measured during various tasks on a 5 point scale, ranging from 0-4. "0" indicates the lowest level of function and "4" the highest level of function, with a total possible score of 56. A score of 20 or less indicates a high fall risk.

Secondary Outcomes

  • Pre-intervention: Amputee Mobility Predictor (AMP)(Week 12-13)
  • Pre-intervention: Modified Falls Efficacy Scale (mFES)(Week 12-13)
  • Post-intervention: Amputee Mobility Predictor (AMP)(Week 24-25)
  • Post-intervention: Modified Falls Efficacy Scale (mFES)(Week 24-25)
  • Delayed post-intervention: Modified Falls Efficacy Scale (mFES)(Week 40-41)
  • Delayed post-intervention: Amputee Mobility Predictor (AMP)(Week 40-41)

Study Sites (3)

Loading locations...

Similar Trials